[1]
Sá, A. et al. 2022. The Impact of Biological Drugs in Patients with Rheumatoid Arthritis. Internal Medicine. 25, 3 (Apr. 2022), 201–207. DOI:https://doi.org/10.24950/rspmi/original/355/3/2018.